BMRA

Biomerica, Inc. (BMRA) ESG Analysis Analysis (2026)

Invetso Score: 5.9/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.6 (Moderate)

BMRA’s R&D intensity of 17.7% of revenue suggests some resource commitment to product development, but peers with larger scale typically spread environmental compliance costs more efficiently.

The company’s low gross margin of 8.1% can constrain funding for emissions, waste, and process-improvement initiatives, leaving it less resilient than better-capitalized peers.

Negative net debt to EBITDA indicates limited balance-sheet pressure, which can support incremental environmental investments, though this advantage is modest versus peers with stronger operating cash generation.

No filing-based evidence provided here indicates material environmental controversies, but the available metrics do not show a clear sustainability leadership position versus peers.

Social

Score:

Stock-based compensation at 18.0% of revenue can align employees with long-term outcomes, yet it also signals heavier dilution pressure than many peers with lower compensation intensity.

BMRA’s modest R&D spend may support product quality and innovation, but peers with deeper development budgets are better positioned to address patient, customer, or user needs over time.

Low profitability limits room for workforce investment, training, and service quality programs, making social execution more dependent on cost discipline than peer leaders.

No latest provided evidence shows major labor or community controversies, but the disclosed metrics indicate an average rather than differentiated social profile versus peers.

Governance

Score:

Debt-to-equity of 0.72 suggests moderate leverage, which is manageable but less conservative than peers with cleaner balance sheets and lower refinancing risk.

Negative net debt to EBITDA implies some liquidity cushion, improving governance resilience relative to more levered peers facing tighter covenant or capital-allocation pressure.

Stock-based compensation at 18.0% of revenue can support retention, but it also raises governance scrutiny because dilution risk is higher than at peers with tighter pay discipline.

The provided metrics do not indicate severe governance failures, yet they also do not evidence the stronger capital discipline typically seen in top-tier peer groups.

Overall Score

Score:

BMRA screens as a mid-pack ESG name versus peers because balance-sheet flexibility offsets weak profitability, while the available metrics do not show a clear leadership position.

Score Driver: Limited Operating Profitability Constrains ESG Investment Capacity Relative To Peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Biomerica, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →